Thus, the ceramide-CD300f binding inhibits CLP-induced neutrophil accumulation to sites of infection as well as IgE-dependent allergic reactions, ATP-mediated experimental colitis, or LPS-induced skin inflammation; however, the ceramide-CD300f binding is either detrimental or beneficial to human health in the former and latter case, respectively13. Here, CD300LF is linked to infection.